Abstract PURPOSE: In a randomized, double-blind, comparative, multicenter trial, liposomal amphotericin B was equivalent to conventional amphotericin B for empirical antifungal therapy in febrile ...

Liposomal amphotericin B represents a pivotal advance in antifungal chemotherapy, combining the potent polyene amphotericin B with phospholipid vesicles to enhance therapeutic index. Encapsulation ...

Liposomal amphotericin B (L-AMB) may have less renal toxicity than amphotericin B lipid complex (ABLC), making it the "preferred agent" in patients with baseline renal impairment being treated for ...

These findings support the safety and use of single high-dose liposomal amphotericin B over alternative treatment options. For patients with HIV-associated fungal infections, single high-dose ...

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 25, 2021 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to ...

India's Central Drugs Standard Control Organization has approved Taiwan Liposome Company's (NASDAQ: TLC) marketing application for Amphotericin B Liposome for 50mg Injection for immediate import to ...

Cryptococcal meningitis is a major complication of HIV infection. In this phase 3, randomized, controlled trial in sub-Saharan Africa, a single dose of liposomal amphotericin B induction therapy ...

To investigate the impact of PCR as a diagnostic tool for guiding preemptive antifungal therapy, we compared the incidence of IFIs as well as the overall and IFI-related mortality in patients after ...

To the Editor: In the important study by Walsh et al. (Sept. 30 issue), 1 the most unexpected finding was the difference in response rates between the liposomal amphotericin B group and the ...

The Centre on Monday allotted additional 1,06,300 vials of Liposomal Amphotericin B, the drug used for Black Fungus treatment, to states, UTs as well as central institutions. The Centre has also ...

PURPOSE: In a randomized, double-blind, comparative, multicenter trial, liposomal amphotericin B was equivalent to conventional amphotericin B for empirical antifungal therapy in febrile neutropenic ...